China Dasheng Biotechnology Company
CDBT · OTC
6/30/2023 | 6/30/2022 | 6/30/2008 | 10/31/2007 | |
|---|---|---|---|---|
| Revenue | $0 | – | $16,294 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | – | $8,790 | $2 |
| Gross Profit | $0 | – | $7,504 | -$2 |
| % Margin | – | – | 46.1% | – |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $561 | – | $0 | $0 |
| SG&A Expenses | $561 | – | $2,429 | $8 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $0 | $0 |
| Operating Expenses | $657 | – | $2,429 | $8 |
| Operating Income | -$657 | – | $5,075 | -$10 |
| % Margin | – | – | 31.1% | – |
| Other Income/Exp. Net | -$309 | – | $2,713 | $0 |
| Pre-Tax Income | -$967 | – | $7,788 | -$10 |
| Tax Expense | $0 | – | $0 | $0 |
| Net Income | -$967 | – | $4,638 | -$68 |
| % Margin | – | – | 28.5% | – |
| EPS | -0.024 | – | 0.15 | -0.01 |
| % Growth | – | – | 1,600% | – |
| EPS Diluted | -0.024 | – | 0.15 | -0.01 |
| Weighted Avg Shares Out | 40,976 | – | 30,000 | 9,803 |
| Weighted Avg Shares Out Dil | 40,976 | – | 30,000 | 9,803 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $159 | $0 |
| Interest Expense | $360 | – | $42 | $0 |
| Depreciation & Amortization | $21 | – | $626 | $2 |
| EBITDA | -$637 | – | $5,701 | -$8 |
| % Margin | – | – | 35% | – |